Exploring the oral manifestations of Hepatitis C in children and their diagnostic significance for early liver disease detection.
How glecaprevir/pibrentasvir (G/P) is revolutionizing Hepatitis C treatment for underserved populations with 98% cure rates across all patient groups.
Exploring how IL28B gene variants and liver enzyme profiles predict HCV treatment outcomes in Egypt's unique genotype 4 population.
Exploring how insulin resistance and hyperferritinemia affect interferon gamma levels and treatment response in Egyptian HCV patients